Your browser doesn't support javascript.
loading
Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff.
Duchnowska, Renata; Sperinde, Jeff; Chenna, Ahmed; Haddad, Mojgan; Paquet, Agnes; Lie, Yolanda; Weidler, Jodi M; Huang, Weidong; Winslow, John; Jankowski, Tomasz; Czartoryska-Arlukowicz, Bogumila; Wysocki, Piotr J; Foszczynska-Kloda, Malgorzata; Radecka, Barbara; Litwiniuk, Maria M; Zok, Jolanta; Wisniewski, Michal; Zuziak, Dorota; Biernat, Wojciech; Jassem, Jacek.
Afiliación
  • Duchnowska R; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Sperinde J; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Chenna A; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Haddad M; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Paquet A; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Lie Y; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Weidler JM; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Huang W; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Winslow J; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Jankowski T; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Czartoryska-Arlukowicz B; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Wysocki PJ; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Foszczynska-Kloda M; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Radecka B; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Litwiniuk MM; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Zok J; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Wisniewski M; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Zuziak D; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Biernat W; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
  • Jassem J; Authors' Affiliations: Military Institute of Medicine, Warsaw; Lublin Oncology Center, Lublin; Bialystok Oncology Center, Bialystok; Greater Poland Cancer Center, Poznan; West Pomeranian Oncology Center, Szczecin; Opole Oncology Center, Opole; Warmia and Masuria Oncology Center, Olsztyn; Bydgoszcz O
Clin Cancer Res ; 20(10): 2805-13, 2014 May 15.
Article en En | MEDLINE | ID: mdl-24668646
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article